WHO ICTRP trial
the study of the diagnostic value of DNA methylation in blood and stool in…
ChiCTR2100048569 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2100048569 |
|---|---|
| Public title | the study of the diagnostic value of DNA methylation in blood and stool in colorectal cancer |
| Scientific title | the study of the diagnostic value of DNA methylation in blood and stool in colorectal cancer |
| Primary sponsor | Renji Hospital, Shanghai Jiaotong University School of Medicine |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Diagnostic test |
| Phase | 0 |
| Countries | China |
| Conditions | colorectal cancer |
| Interventions | Gold Standard:Colonoscopy biopsy;Index test:detection of novel DNA methylation sites in stool and blood |
| Registration date | Jul 10, 2021 |
| Target size | Target condition:400;Difficult condition:0 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: